Filter by ContentType
Automated plasmid assembly: a perspective from early drug discovery
S Ahammu, J Chi, T Edström et al
18 December 2024
Expert Insight
Therapeutic epigenome editing: safety and quality considerations of a new class of gene-targeted medicines
Houria Bachtarzi, Tim Farries
15 October 2024
Expert Insight
MHRA regulatory considerations for the quality of mRNA products
Ka-Wai Wan, Francis Galaway
22 May 2024
Expert Insight
Insights into manufacturing lab-scale in vitro transcribed RNA modalities
Andrew Varley
21 May 2024
Expert Insight
Challenges and advances of the stability of mRNA delivery therapeutics
Jin Zhai, Trystin Cote, Yupeng Chen
13 March 2024
Expert Insight
The supporting role of plasmids in gene & cell therapy
Duarte Prazeres
06 July 2023
Expert Insight
A blueprint for quality by digital design to support rapid RNA vaccine process development, manufacturing & supply
S Daniel, Z Kis, C Kontoravdi et al
22 September 2022
Expert Insight
Unleashing the full potential of cell therapy through RNA engineering
Metin Kurtoglu
11 May 2022
Expert Insight
Next-generation DNA vectors: is the nS/MARt platform a viable alternative to viruses for autologous T-cell immunotherapy?
Matthias Bozza, Richard Harbottle
23 November 2021
Expert Insight
DNA-encoded immunotherapeutics: ready for blast-off?
Diana Guimet, Trevor RF Smith, Jeffrey M. Skolnik
01 December 2020
Expert Insight